Ventilator-associated pneumonia: the influence of bacterial resistance, prescription errors, and de-escalation of antimicrobial therapy on mortality rates
Ventilator-associated pneumonia is the most prevalent nosocomial infection in intensive care units and is associated with high mortality rates (14–70%). Aim: This study evaluated factors influencing mortality of patients with Ventilator-associated pneumonia (VAP), including bacterial resistance, pre...
Main Authors: | Ana Carolina Souza-Oliveira, Thúlio Marquez Cunha, Liliane Barbosa da Silva Passos, Gustavo Camargo Lopes, Fabiola Alves Gomes, Denise Von Dolinger de Brito Röder |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-09-01
|
Series: | Brazilian Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1413867016301143 |
Similar Items
-
The effectiveness of a bundle in the prevention of ventilator-associated pneumonia
by: Cléria Rodrigues Ferreira, et al.
Published: (2016-05-01) -
Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study
by: Tracy Trupka, et al.
Published: (2017-07-01) -
Antimicrobial prescription patterns and ventilator associated pneumonia: findings from a 10-site prospective audit
by: Rosalind M. Elliott, et al.
Published: (2018-10-01) -
Antibiotics De-Escalation in the Treatment of Ventilator-Associated Pneumonia in Trauma Patients: A Retrospective Study on Propensity Score Matching Method
by: Hu Li, et al.
Published: (2018-01-01) -
Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia
by: Khasawneh FA, et al.
Published: (2014-06-01)